These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37852321)

  • 1. Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy.
    Liu M; Zhai L; Yang Z; Li S; Liu T; Chen A; Wang L; Li Y; Li R; Li C; Tan M; Chen Z; Qian J
    Mol Cell Proteomics; 2023 Dec; 22(12):100667. PubMed ID: 37852321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
    Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
    BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V; Matteucci M; Ribezzo M; Di Silvestre D; Brambilla F; Agostini S; Mauri P; Padeletti L; Pingitore A; Delsedime L; Rinaldi M; Recchia FA; Pucci A
    J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
    Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C
    Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
    Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
    PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy.
    Karch R; Neumann F; Ullrich R; Neumüller J; Podesser BK; Neumann M; Schreiner W
    Cardiovasc Pathol; 2005; 14(3):135-44. PubMed ID: 15914298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling reveals genes and transcription factors associated with dilated and ischemic cardiomyopathies.
    Qiao A; Zhao Z; Zhang H; Sun Z; Cui X
    Pathol Res Pract; 2017 May; 213(5):548-557. PubMed ID: 28318762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy].
    Cortés R; Portolés M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Salvador A; Rivera M
    Rev Esp Cardiol; 2007 Dec; 60(12):1319-23. PubMed ID: 18082099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.
    Roselló-Lletí E; Alonso J; Cortés R; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Lago F; Azorín I; Juanatey JR; Portolés M; Rivera M
    J Cell Mol Med; 2012 Oct; 16(10):2471-86. PubMed ID: 22435364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Ischaemic and Dilated Cardiomyopathy on Short-Term and Long-Term Survival After Ventricular Assist Device Implantation: A Single-Centre Experience.
    Ivanov B; Djordjevic I; Sabashnikov A; Sindhu D; Hink S; Eghbalzadeh K; Gerfer S; Gaisendrees C; Schlachtenberger G; Rustenbach C; Seuthe K; Regnier K; Mader N; Pfister R; Zeriouh M; Rahmanian P; Wahlers T
    Heart Lung Circ; 2022 Mar; 31(3):383-389. PubMed ID: 34598889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics.
    Huang G; Huang Z; Peng Y; Wang Y; Liu W; Xue Y; Yang W
    Pharmgenomics Pers Med; 2021; 14():1169-1184. PubMed ID: 34557019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A; Bloch W; Antonyan A; Goebel H; Fries JU; Schlensak C; Beyersdorf F; Geissler HJ
    Lymphology; 2010 Sep; 43(3):110-7. PubMed ID: 21226413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models.
    Lu D; Xia Y; Chen Z; Chen A; Wu Y; Jia J; Sun A; Zou Y; Qian J; Ge J
    Front Physiol; 2019; 10():750. PubMed ID: 31275164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3.
    Reitz CJ; Tavassoli M; Kim DH; Shah S; Lakin R; Teng ACT; Zhou YQ; Li W; Hadipour-Lakmehsari S; Backx PH; Emili A; Oudit GY; Kuzmanov U; Gramolini AO
    Proc Natl Acad Sci U S A; 2023 May; 120(19):e2212118120. PubMed ID: 37126683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
    Cabiati M; Svezia B; Matteucci M; Botta L; Pucci A; Rinaldi M; Caselli C; Lionetti V; Del Ry S
    PLoS One; 2016; 11(8):e0160110. PubMed ID: 27479215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
    Flesch M; Schwinger RH; Schnabel P; Schiffer F; van Gelder I; Bavendiek U; Südkamp M; Kuhn-Regnier F; Böhm M
    J Mol Med (Berl); 1996 Jun; 74(6):321-32. PubMed ID: 8862513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of beta1D-integrin function in human ischemic cardiomyopathy.
    Pfister R; Acksteiner C; Baumgarth J; Burst V; Geissler HJ; Margulies KB; Houser S; Bloch W; Flesch M
    Basic Res Cardiol; 2007 May; 102(3):257-64. PubMed ID: 17186162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy.
    Koumi S; Backer CL; Arentzen CE
    Circulation; 1995 Jul; 92(2):164-74. PubMed ID: 7600647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.